| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 22nd December 2020 | Thomas C Dircks | 46,299 | Bona fide gift | $0.00 | |
| 22nd December 2020 | Thomas C Dircks | 46,299 | Bona fide gift | $0.00 | |
| 22nd December 2020 | Thomas C Dircks | 74,005 | Bona fide gift | $0.00 | |
| 22nd December 2020 | Thomas C Dircks | 74,005 | Bona fide gift | $0.00 | |
| 8th December 2020 | Thomas C Dircks | 1,521 | Open or private sale | $39.67 | $60,339.90 |
| 8th December 2020 | Thomas C Dircks | 417 | Open or private sale | $42.51 | $17,726.67 |
| 8th December 2020 | Thomas C Dircks | 7,603 | Open or private sale | $39.67 | $301,620.13 |
| 8th December 2020 | Thomas C Dircks | 83 | Open or private sale | $42.51 | $3,528.33 |
| 8th December 2020 | Thomas C Dircks | 37,192 | Open or private sale | $40.72 | $1,514,580.97 |
| 8th December 2020 | Thomas C Dircks | 4,788 | Open or private sale | $41.58 | $199,094.62 |
Cross Country Healthcare
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the following segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The company was founded in 1975 and is headquartered in Boca Raton, FL.
Ticker: CCRN
Sector: Industrials
Industry: Staffing & Employment Services
SEC Central Index Key (CIK): 1141103
Employees: 1750
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Restructuring Charges of $2 M for the period Apr 2020 to Jun 2020 in the context of all up
Restructuring Charges of $2 M for the period Apr 2020 to Jun 2020 in the context of A2019 restructuring plan
Restructuring Charges of $535 Th for the period Apr 2020 to Jun 2020 in the context of Exit costs
Restructuring Charges of $3 M for the period Jan 2020 to Jun 2020 in the context of all up
Restructuring Charges of $200 Th for the period Jan 2020 to Jun 2020 in the context of Legal entity reorganization
Restructuring Charges of $300 Th for the period Jan 2020 to Jun 2020 in the context of Strategic reduction of real estate footprint
Restructuring Charges of $100 Th for the period Jan 2020 to Jun 2020 in the context of Other restructuring
Restructuring Charges of $212 Th for the period Jan 2020 to Mar 2020 in the context of A2019 restructuring plan
Restructuring Charges of $20 Th for the period Jan 2020 to Mar 2020 in the context of Exit costs
Restructuring Charges of $137 Th for the period Apr 2019 to Jun 2019 in the context of all up
Restructuring Charges of $1 M for the period Jan 2019 to Jun 2019 in the context of all up
Revenue From Related Parties of $2 M for the period Apr 2020 to Jun 2020 in the context of Corporate joint venture
Revenue From Related Parties of $8 M for the period Jan 2020 to Jun 2020 in the context of Corporate joint venture
Revenue From Related Parties of $6 M for the period Apr 2019 to Jun 2019 in the context of Corporate joint venture
Revenue From Related Parties of $12 M for the period Jan 2019 to Jun 2019 in the context of Corporate joint venture
Goodwill Impairment Loss of $0 for the period Jan 2020 to Jun 2020 in the context of Nurse and allied staffing
Goodwill Impairment Loss of $10 M for the period Jan 2020 to Jun 2020 in the context of Search services
Fundamentals
Cash at Carrying Value: $6 M (504%)
Other Assets, Current: $2 M (17%)
Assets, Current: $175 M (-4%)
Property, Plant and Equipment, Net: $12 M (1%)
Other Assets, Noncurrent: $18 M (0%)
Assets: $352 M (-7%)
Liabilities, Current: $99 M (15%)
Other Liabilities, Noncurrent: $7 M (63%)
Liabilities: $203 M (-7%)
Common Stock, Value, Issued: $4 Th (0%)
Additional Paid in Capital, Common Stock: $308 M (0%)
Retained Earnings (Accumulated Deficit): $158 M (11%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $1 M (7%)
Stockholders' Equity (Parent): $149 M (-8%)
Liabilities and Equity: $352 M (-7%)
Revenue: $217 M (-49%)
Restructuring Charges: $2 M (0%)
Operating Income/Loss: $14 M (0%)
Income before taxes: $14 M (-9%)
Provision for income taxes: $379 Th (88%)
News
The Best Small-Cap Stocks To Buy Because Of The January Effect
18th December 2020
The Grinch Could Derail The Santa Claus Rally This Year
4th December 2020
The Top Stocks To Buy If COVID-19 Causes A Sell-Off
20th November 2020
